ArticleCells2020

Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs).

Julia Hambach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.